Table 2

Prevalence of antihypertensive medication recommendations according to the different hypertension management guidelines in the Heinz Nixdorf Recall cohort

Threshold for initiating antihypertensive medication treatmentAntihypertensive medication recommendation among participants hitherto not taking antihypertensive medication*, n (%, 95% CI)
JNC7 2003≥140/90 mm Hg in all and ≥130/80 mm Hg in high cardiovascular risk patients1146 (37.2, 35.5 to 38.9)
WHO/ISH 2003≥180/110 mm Hg in all and ≥140/90 mm Hg in high cardiovascular risk patients601 (20.3, 18.9 to 21.8)
ESH/ESC 2013≥160/100 mm Hg in all and ≥140/90 mm Hg in high cardiovascular risk patients523 (17.8, 16.4 to 19.2)
ACC/AHA 2017≥140/90 mm Hg in all and ≥130/80 mm Hg in high cardiovascular risk patients1418 (45.8, 44.0 to 47.6)
ESC/ESH 2018≥160/100 mm Hg in all and ≥140/90 mm Hg in high cardiovascular risk patients821 (26.7, 25.1 to 28.3)
ISH 2020≥160/100 mm Hg in all and ≥140/90 mm Hg in high cardiovascular risk patients772 (25.0, 23.5 to 26.5)
  • *n=3092.

  • ACC, American College of Cardiology; AHA, American Heart Association; ESC, European Society of Cardiology; ESH, European Society of Hypertension; ISH, International Society of Hypertension; ; JNC7, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 7.